Expression patterns of VEGF, VEGFR1 and VEGFR2 in canine corpus luteum (CL) during the course of dioestrus.

被引：0
|
作者：
Papa, Paula C.
Kowalewski, Mariusz P.
Willhelm, Eva
Artoni, Laura P.
Garbelotti, Fernando
Marques, Jose E. B., Jr.
Buratini, Jose, Jr.
Hoffmann, Bernd
机构：
[1] Univ Sao Paulo, Sao Paulo, Brazil
[2] Univ Giessen, Giessen, Germany
[3] Univ State Sao Paulo, Botucatu, SP, Brazil
来源：
BIOLOGY OF REPRODUCTION | 2006年
关键词：
D O I：
暂无
中图分类号：
Q [生物科学];
学科分类号：
07 ; 0710 ; 09 ;
摘要：
引用
收藏
页码：168 / 169
页数：2
相关论文
共 50 条
  • [41] Molecular cloning and expression of StAR protein in the canine corpus luteum during dioestrus
    Kowalewski, M. P.
    Hoffmann, B.
    EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2008, 116 (03) : 158 - 161
  • [42] Microvessel density and expression of the angiogenic proteins VEGF, VEGFR1, VEGFR2 and HIF-1α in Hodgkin and Reed-Sternberg cells of classical Hodgkin lymphoma
    Lampri, Evangeli
    Simou, Nafsika
    Briasoulis, Evangelos
    Goussia, Ann
    Kamina, Sevasti
    Nikiforidis, Lazaros
    Demou, Asimina
    Malamou-Mitsi, Vasiliki
    Pavlidis, Nikolaos
    Agnantis, Niki J.
    Kanavaros, Panagiotis
    Bai, Maria
    VIRCHOWS ARCHIV, 2007, 451 (02) : 438 - 438
  • [43] Association of VEGFR1, VEGFR2 and VEGFR3 polymorphisms with esophageal cancer risk: a case-control study
    Walia, Sukhpreet Kaur
    Sambyal, Vasudha
    Sudan, Meena
    Uppal, Manjit Singh
    Guleria, Kamlesh
    EGYPTIAN JOURNAL OF MEDICAL HUMAN GENETICS, 2024, 25 (01)
  • [44] 血清中VEGF,VEGFR1与VEGFR2在肺癌中的表达及其相互关系
    毛光华
    韩存芝
    张俊萍
    张毅勋
    冯慧晶
    中国现代药物应用, 2009, 3 (22) : 1 - 2
  • [45] Potential inhibitors of VEGFR1, VEGFR2, and VEGFR3 developed through Deep Learning for the treatment of Cervical Cancer
    Nayarisseri, Anuraj
    Abdalla, Mohnad
    Joshi, Isha
    Yadav, Manasi
    Bhrdwaj, Anushka
    Chopra, Ishita
    Khan, Arshiya
    Saxena, Arshiya
    Sharma, Khushboo
    Panicker, Aravind
    Panwar, Umesh
    Mendonca Junior, Francisco Jaime Bezerra
    Singh, Sanjeev Kumar
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [46] THE PROFILE AND SIGNIFICANCE OF VEGF, VEGFR2 AND VEGFR3 EXPRESSION IN ENDOMETRIAL CARCINOMA.
    Wang, J.
    Taylor, A.
    Showeil, R.
    Trivedi, P.
    Horimoto, Y.
    Bagwan, I.
    Ewington, L.
    Lam, E. Y. F.
    El-Bahrawy, M.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2013, 23 (08)
  • [47] VEGFR1 and VEGFR2 Involvement in Extracellular Galectin-1-and Galectin-3-Induced Angiogenesis
    D'Haene, Nicky
    Sauvage, Sebastien
    Maris, Calliope
    Adanja, Ivan
    Le Mercier, Marie
    Decaestecker, Christine
    Baum, Linda
    Salmon, Isabelle
    PLOS ONE, 2013, 8 (06):
  • [48] Association between Tumor Expression of VEGFA, VEGFR1 (FLT1), VEGFR2 (KDR), and Clinical Outcomes in Neuroendocrine Tumors
    Qian, Z.
    Ter-Minassian, M.
    Chan, J. A.
    Imamura, Y. U.
    Hooshmand, S. M.
    Brais, L. K.
    Lin, X.
    Christiani, D. C.
    Fuchs, C. S.
    Ogino, S.
    Kulke, M. H.
    NEUROENDOCRINOLOGY, 2014, 99 (3-4) : 237 - 237
  • [49] Autocrine VEGFR1 and VEGFR2 signaling promotes survival in human glioblastoma models in vitro and in vivo
    Szabo, Emese
    Schneider, Hannah
    Seystahl, Katharina
    Rushing, Elisabeth Jane
    Herting, Frank
    Weidner, K. Michael
    Weller, Michael
    NEURO-ONCOLOGY, 2016, 18 (09) : 1242 - 1252
  • [50] Tumor necrosis factor-α regulates angiogenesis of BeWo cells via synergy of PlGF/VEGFR1 and VEGF-A/VEGFR2 axes
    Tanaka, Kei
    Watanabe, Momoe
    Tanigaki, Shinji
    Iwashita, Mitsutoshi
    Kobayashi, Yoichi
    PLACENTA, 2018, 74 : 20 - 27
12345